Related Experiment Video
Updated: Dec 1, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
MicroRNA-451a targets caveolin-1 in stomach cancer cells
Yi Wang1, Zhenmeng Lin1, Jintian Song1
1Department of Gastrointestinal Surgery, Fujian Cancer Hospital & Fujian Medical University Cancer Hospital Fuzhou 350014, Fujian, China.
Abstract:
MicroRNA-451 (miR-451) is lowly expressed in stomach cancer cells and improves their metastatic ability by down-regulating extracellular signal-regulated kinase 2 (ERK2). Many studies have found that caveolin-1 (CAV1) plays an important role in cancer progression. Additionally, miR-451 has been reported to regulate the expression of CAV1 in chronic obstructive pulmonary disease. Therefore, this study aims to determine if miR-451 regulates the biological functions of stomach cancer cells by regulating CAV1 expression. Through a bioinformatics analysis, we found that miR-451a regulates CAV1 expression, and miR-451a expression is relatively low in stomach cancer cells. Next, we confirmed that miR-451a negatively regulates CAV1 expression using a dual-luciferase reporter assay. Then MTT, 5-ethynyl-2'-deoxyuridine (EdU), propidium iodide (PI), an Annexin V-FITC/PI apoptosis kit, and transwell assays were used to measure the changes in cell proliferation, the cell cycle, apoptosis, cell migration, and invasiveness in stomach cancer cells overexpressing miR-451a or both miR-451a and CAV1. It was found that increasing the miR-451a expression in stomach cancer cells inhibits cell growth, migration, and invasiveness, and promotes apoptosis. After restoring the CAV1 expression, these biological processes resumed. In summary, in stomach cancer cells, the overexpression of miR-451a can restrain cell growth and promote apoptosis, so it is a potential treatment for stomach cancer.
Insights
MicroRNA-451 (miR-451) suppresses stomach cancer growth and metastasis by downregulating caveolin-1 (CAV1). Restoring CAV1 reverses these effects, indicating miR-451
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MicroRNA-451 (miR-451) is downregulated in stomach cancer, correlating with increased metastatic potential.
- Caveolin-1 (CAV1) is implicated in cancer progression, and its regulation by miR-451 has been observed in other diseases.
- The precise role of miR-451 in regulating stomach cancer cell functions via CAV1 remains to be elucidated.
Purpose of the Study:
- To investigate whether miR-451 regulates stomach cancer cell biological functions through modulation of CAV1 expression.
- To determine the therapeutic potential of miR-451 in stomach cancer treatment.
Main Methods:
- Bioinformatic analysis to predict miR-451a-CAV1 interaction.
- Dual-luciferase reporter assay to confirm the regulatory relationship.
- Cell proliferation (MTT, EdU), cell cycle (PI), apoptosis (Annexin V-FITC/PI), migration, and invasion assays were performed on stomach cancer cells with altered miR-451a and CAV1 expression.
Main Results:
- Bioinformatic analysis and luciferase assays confirmed that miR-451a negatively regulates CAV1 expression.
- Overexpression of miR-451a in stomach cancer cells significantly inhibited cell proliferation, migration, and invasion, while promoting apoptosis.
- Restoration of CAV1 expression reversed the inhibitory effects of miR-451a on these cellular processes.
Conclusions:
- Overexpression of miR-451a restrains stomach cancer cell growth, migration, and invasion, and induces apoptosis.
- miR-451a exerts its tumor-suppressive effects in stomach cancer by downregulating CAV1 expression.
- miR-451a represents a potential therapeutic target for stomach cancer.
Related Concept Videos
MicroRNAs
MicroRNAs
Drugs that Stabilize Microtubules
Drugs that Destabilize Microtubules
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation

